144 related articles for article (PubMed ID: 38518732)
21. Atypical melanocytic nevi of the genital type with a discussion of reciprocal parenchymal-stromal interactions in the biology of neoplasia.
Clark WH; Hood AF; Tucker MA; Jampel RM
Hum Pathol; 1998 Jan; 29(1 Suppl 1):S1-24. PubMed ID: 9445124
[TBL] [Abstract][Full Text] [Related]
22. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
[TBL] [Abstract][Full Text] [Related]
23. BRAF and NRAS mutations in spitzoid melanocytic lesions.
Fullen DR; Poynter JN; Lowe L; Su LD; Elder JT; Nair RP; Johnson TM; Gruber SB
Mod Pathol; 2006 Oct; 19(10):1324-32. PubMed ID: 16799476
[TBL] [Abstract][Full Text] [Related]
24. Potential diagnostic utility of PRAME and p16 immunohistochemistry in melanocytic nevi and malignant melanoma.
Bahmad HF; Oh KS; Alexis J
J Cutan Pathol; 2023 Aug; 50(8):763-772. PubMed ID: 37114299
[TBL] [Abstract][Full Text] [Related]
25. Benign melanocytic lymph node deposits in the setting of giant congenital melanocytic nevi: the large congenital nodal nevus.
Bowen AR; Duffy KL; Clayton FC; Andtbacka RH; Florell SR
J Cutan Pathol; 2015 Nov; 42(11):832-9. PubMed ID: 26268779
[TBL] [Abstract][Full Text] [Related]
26. A comparative study of proliferative nodules and lethal melanomas in congenital nevi from children.
Yélamos O; Arva NC; Obregon R; Yazdan P; Wagner A; Guitart J; Gerami P
Am J Surg Pathol; 2015 Mar; 39(3):405-15. PubMed ID: 25517953
[TBL] [Abstract][Full Text] [Related]
27. Congenital melanocytic nevi-when to worry and how to treat: Facts and controversies.
Price HN; Schaffer JV
Clin Dermatol; 2010; 28(3):293-302. PubMed ID: 20541682
[TBL] [Abstract][Full Text] [Related]
28. [Immunohistochemical analysis of ras gene expression in human melanomas and melanocytic nevi].
Yasuda H
Hokkaido Igaku Zasshi; 1989 May; 64(3):243-53. PubMed ID: 2670726
[TBL] [Abstract][Full Text] [Related]
29. PRAME Immunohistochemical Expression and TERT Promoter Mutational Analysis as Ancillary Diagnostic Tools for Differentiating Proliferative Nodules From Melanoma Arising in Congenital Nevi.
Boutko A; Hagstrom M; Lampley N; Roth A; Olivares S; Dhillon S; Fumero-Velázquez M; Benton S; Zhao J; Zhang B; Dittmann D; Asadbeigi S; Busam KJ; Gerami P
Am J Dermatopathol; 2023 Jul; 45(7):437-447. PubMed ID: 37338065
[TBL] [Abstract][Full Text] [Related]
30. Melanoma arising in a Giant congenital melanocytic nevus: two case reports.
Belysheva TS; Vishnevskaya YV; Nasedkina TV; Emelyanova MA; Abramov IS; Orlova KV; Lubchenko LN; Utyashev IA; Doroshenko MB; Demidov LV; Aliev MD
Diagn Pathol; 2019 Feb; 14(1):21. PubMed ID: 30782194
[TBL] [Abstract][Full Text] [Related]
31. A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma.
Clark WH; Elder DE; Guerry D; Epstein MN; Greene MH; Van Horn M
Hum Pathol; 1984 Dec; 15(12):1147-65. PubMed ID: 6500548
[TBL] [Abstract][Full Text] [Related]
32. Melanoma Developing from an Intradermal Nevus: Report on Two Patients.
Ledić Drvar D; Radoš J; Manola I; Mataić A; Dotlić S; Krušlin B
Acta Dermatovenerol Croat; 2023 Aug; 31(1):40-42. PubMed ID: 37843090
[TBL] [Abstract][Full Text] [Related]
33. Black and Brown Oro-facial Mucocutaneous Neoplasms.
Natarajan E
Head Neck Pathol; 2019 Mar; 13(1):56-70. PubMed ID: 30693458
[TBL] [Abstract][Full Text] [Related]
34. Proliferative activity of primary cutaneous melanocytic tumours.
Kuwata T; Kitagawa M; Kasuga T
Virchows Arch A Pathol Anat Histopathol; 1993; 423(5):359-64. PubMed ID: 7906909
[TBL] [Abstract][Full Text] [Related]
35. Genomic aberrations in spitzoid melanocytic tumours and their implications for diagnosis, prognosis and therapy.
Wiesner T; Kutzner H; Cerroni L; Mihm MC; Busam KJ; Murali R
Pathology; 2016 Feb; 48(2):113-31. PubMed ID: 27020384
[TBL] [Abstract][Full Text] [Related]
36. Amplification of Mutant NRAS in Melanocytic Tumors With Features of Spitz Tumors.
Cloutier JM; Wang M; Vemula SS; Mirza S; Weier J; Aquino JD; McCalmont TH; LeBoit PE; Bastian BC; Yeh I
Mod Pathol; 2024 May; 37(5):100469. PubMed ID: 38467248
[TBL] [Abstract][Full Text] [Related]
37. PRAME expression by immunohistochemistry and reverse transcription quantitative PCR in conjunctival melanocytic lesions-a comprehensive clinicopathologic study of 202 cases and correlation of cytogenetics with PRAME expression in challenging conjunctival melanocytic lesions.
Mudhar HS; Milman T; Stevenson S; Watson M; Kim J; Magan T; Salvi SM; Harley U; Lally SE; Shields CL
Hum Pathol; 2023 Apr; 134():1-18. PubMed ID: 36804828
[TBL] [Abstract][Full Text] [Related]
38. Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancer.
Bastian BC
Oncogene; 2003 May; 22(20):3081-6. PubMed ID: 12789284
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic utility of PRAME in distinguishing proliferative nodules from melanoma in giant congenital melanocytic nevi.
Gill P; Prieto VG; Austin MT; Giubellino A; Torres-Cabala CA
J Cutan Pathol; 2021 Nov; 48(11):1410-1415. PubMed ID: 34164835
[TBL] [Abstract][Full Text] [Related]
40. Paediatric melanoma: clinical update, genetic basis, and advances in diagnosis.
Merkel EA; Mohan LS; Shi K; Panah E; Zhang B; Gerami P
Lancet Child Adolesc Health; 2019 Sep; 3(9):646-654. PubMed ID: 31204309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]